Pharma Journalist -

Sequanta Technologies Co., Ltd. and Mission Bio. are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using…
Read More...

SRI International (SRI) announced that the company has entered a research collaboration with Sanofi. By leveraging SRI’s SynFini platform, an artificial intelligence (AI)-guided,…
Read More...

For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral…
Read More...

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. By adding Pharmatech…
Read More...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its…
Read More...

SMi reports: Understanding the principles of RNA activation and possibilities of therapeutic benefit at Oligonucleotide Therapeutics and Delivery Conference 2021 Engage in the latest…
Read More...

SMi Reports: Explore evolving device design and innovations for high volume and high viscous delivery and delve into regulatory updates on device development and human factors with…
Read More...

Eureka Therapeutics, Inc. announced that Eureka and Memorial Sloan Kettering Cancer Center (MSK) entered into a license agreement with Sanofi for the non-CAR use of a novel, human…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other parts of Asia,…
Read More...